Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Glycine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 2-step synthesis for D-p-hydroxyphenylglycine methyl ester hydrochloride. Reduces cost and waste for amoxicillin production. High purity and yield.
Patent CN116875576B reveals mutant LeuDH for L-phenylglycine. Offers high conversion, ee >99%, and scalable biocatalysis for pharmaceutical supply chains.
Novel BsLDH mutant enables efficient chiral amino acid synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN120555388A reveals enhanced leucine dehydrogenase mutants for high-purity L-phenylglycine synthesis, offering significant supply chain and cost advantages.
Advanced liquid-liquid extraction method for 3-chloro-phenylglycine enantiomers using chiral ferrocene ligands. Offers high separation factors and scalable manufacturing for global supply chains.
Patent CN106497843B reveals high-purity biocatalytic route. Reduces costs and enhances supply chain reliability for diabetes drug intermediates.
Novel recombinant E. coli route for D-HPG production offers cost reduction in API intermediate manufacturing and enhanced supply chain reliability for global pharmaceutical partners.
Novel chemical synthesis route for Saxagliptin intermediate eliminates enzymatic steps. Offers high yield and scalable production for reliable pharmaceutical intermediate supply chains.
Patent CN104829478A details a high-purity crystallization process for pharmaceutical intermediates, offering significant supply chain stability and cost reduction advantages.
Patent CN115820584A reveals high-efficiency mutants for L-phenylglycine and L-2-aminobutyric acid synthesis, offering cost reduction and supply reliability.
Patent CN115710194B enables continuous MGDA production with 98.5% yield. Eliminate NTA impurities and reduce costs in chelating agent manufacturing.
Patent CN101003822A reveals immobilized enzyme hydrolysis for high-purity D-amino acids. Offers scalable production and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110550992A reveals green photocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel phase transfer catalysis method for p-chlorophenylglycine improves yield and purity for pharmaceutical intermediates manufacturing supply chain efficiency and cost.
Advanced synthesis route for high-purity antibiotic intermediates. Improves yield and stability via novel mother liquor recycling technology.
Patent CN110452920A reveals high-efficiency enzymatic route for L-phenylglycine, offering supply chain stability and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN104910032A reveals an eco-friendly anilino-acetate process reducing waste and cost. Ideal for reliable dye intermediate supplier partnerships.
Patent CN106119272A reveals efficient enzymatic co-production reducing cofactor costs for pharmaceutical intermediate manufacturing supply chains and enhancing scalability.
Patent CN106366010B reveals a safer halosilane reduction method for high-purity Saxagliptin intermediates, offering significant cost and supply chain advantages.
Patent CN114507650B reveals a mutant enzyme boosting yield and purity for Clopidogrel intermediates, ensuring stable supply chains and reduced manufacturing costs for global buyers.